Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Current Assets (2019 - 2025)

Pulmonx has reported Current Assets over the past 7 years, most recently at $101.7 million for Q4 2025.

  • Quarterly Current Assets fell 25.37% to $101.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $101.7 million through Dec 2025, down 25.37% year-over-year, with the annual reading at $101.7 million for FY2025, 25.37% down from the prior year.
  • Current Assets was $101.7 million for Q4 2025 at Pulmonx, down from $111.2 million in the prior quarter.
  • Over five years, Current Assets peaked at $239.3 million in Q1 2021 and troughed at $101.7 million in Q4 2025.
  • The 5-year median for Current Assets is $157.4 million (2023), against an average of $166.3 million.
  • Year-over-year, Current Assets surged 309.27% in 2021 and then decreased 25.37% in 2025.
  • A 5-year view of Current Assets shows it stood at $208.0 million in 2021, then dropped by 18.77% to $169.0 million in 2022, then fell by 10.97% to $150.4 million in 2023, then dropped by 9.42% to $136.2 million in 2024, then decreased by 25.37% to $101.7 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Current Assets are $101.7 million (Q4 2025), $111.2 million (Q3 2025), and $120.0 million (Q2 2025).